The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order contract worth $13,907.30 to Illumina, Inc. for the maintenance of laboratory equipment. The contract has a period of performance through July 20, 2024 and does not have a socioeconomic set-aside designation. Illumina is a manufacturer and provider of genetic and genomic analysis instruments and reagents, and has previously provided sequencing systems and services to support research and diagnostics work across various federal agencies. This contract award appears to be associated with the CDC's broader needs for maintaining scientific instrumentation utilized at its Pittsburgh, Pennsylvania facility.
Generated 8/13/24, 11:59 AM